Michael R McAlevey sold $1.8M of HCA
EVP & Chief Legal & Admin Off. at HCA Healthcare, Inc.. 3,892 shares at an average of $473.79, traded Nov 5, 2025, filed Nov 5, 2025.
Score components
- +15RoleOfficer
- +25Trade size$1.8M at market
- +20Share of holdings soldSold 53% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +2.9%, 3m +4.5%, 6m -9.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-267409, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 3, 2025 | MOption exercise Common Stock | +13,170 | $236.61 | $3.1M | 16,657 | Nov 5, 2025 |
| Nov 3, 2025 | FTax withholding Common Stock | -9,278 | $461.56 | $4.3M | 7,379 | Nov 5, 2025 |
| Nov 5, 2025 | SOpen-market sale Common Stock | -3,892 | $473.79 | $1.8M | 3,487 | Nov 5, 2025 |
| Nov 3, 2025 | MOption exercise Stock Appreciation Rightderivative | -13,170 | $0.00 | $0 | 0 | Nov 5, 2025 |
Related signals
Other insiders at HCA Healthcare, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 44Moderate | HCA Healthcare, Inc. | Michael R McAlevey EVP & Chief Legal & Admin Off. | $904k 1,694 shares | -16% | |
| 65Notable | HCA Healthcare, Inc. | Jennifer Berres SVP & Chief Human Res. Officer | $4.1M 8,020 shares | -40% | |
| 55Moderate | HCA Healthcare, Inc. | Christopher F. Wyatt SVP & Controller | $2.0M 4,000 shares | -8% | |
| 51Moderate | HCA Healthcare, Inc. | Michael S. Cuffe EVP and Chief Clinical Officer | $747k 1,500 shares | -5% | |
| 85Strong | HCA Healthcare, Inc. | Samuel N Hazen CEO | $21M 42,877 shares | -57% | |
| 10Weak | HCA Healthcare, Inc. | Michael S. Cuffe EVP and Chief Clinical Officer | $1.6M 3,836 shares | -11% | |
| 65Notable | HCAsell HCA Healthcare, Inc. | Jon M Foster EVP and COO | $5.8M 15,698 shares | -55% | |
| 24Weak | HCAbuy HCA Healthcare, Inc. | Bank Of America Corp /de/ owner | $88k 3,436 shares | - | |
| 41Moderate | HCAsell HCA Healthcare, Inc. | Bank Of America Corp /de/ owner | $80k 3,178 shares | -666% | |
| 50Moderate | HCAsell HCA Healthcare, Inc. | Jennifer Berres SVP & Chief Human Res. Officer | $3.1M 9,533 shares | -38% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.